Changes To The Opioid Dependence Treatment Program: Implications for Access and Transitional Arrangements

This online forum was for people working within Opioid Dependence Treatment in Australia. 

COST Free
DATE 27 Jun 2023
TIME 2:00 अपराह्न - 4:00 अपराह्न
DELIVERY Online
SPEAKERSDavid Laffan, / Pharmacy Branch, Australian Government Department of Health and Aged CareKirsten Buckingham / Alcohol and Other Drugs Branch, Australian Government Department of Health and Aged CareRebecca Lang / AADC Board and CEO, Queensland Network of Alcohol and Other Drug Agencies (QNADA)More
TICKETED Yes
ACCESSIBILITY Yes

An Australian Alcohol and other Drugs Council (AADC) and Australian Injecting and Illicit Drug Users League (AIVL) online event

In the May 2023 Federal Budget, it was announced that from 1 July 2023 the more than 50,000 Australians who need treatment for opioid dependency will have funded support to access the treatment they need from their local pharmacy at a cost they can afford, through a $377.3 million investment over 4 years in the Pharmaceutical Benefits Scheme (PBS) Opioid Dependence Treatment program (ODTP). The resultant changes and transitional arrangements will be outlined and discussed at this event, with the online audience having an opportunity to ask any questions arising ahead of implementation.

Program

  • Welcome, Acknowledgement of Country and introduction to event
    Melanie Walker, CEO, AADC
  • Introduction to AIVL, its current work and strategic priorities
    John G, CEO, AIVL
  • Outline of ODTP changes and transitional arrangements from 1 July 2023
    David Laffan, Assistant Secretary, Pharmacy Branch, Australian Government Department of Health and Aged Care
  • Forum with panellists and audience participation to discuss the changes and transitional arrangements.

David Laffan,

Pharmacy Branch, Australian Government Department of Health and Aged Care

Assistant Secretary

Kirsten Buckingham

Alcohol and Other Drugs Branch, Australian Government Department of Health and Aged Care

Director

Rebecca Lang

AADC Board and CEO, Queensland Network of Alcohol and Other Drug Agencies (QNADA)

Deputy Chair

Stephanie Hocking

Centre for Alcohol and Other Drugs, NSW Ministry of Health

Director of Clinical Services and Programs

Chris Gough

President, AIVL and Executive Director, Canberra Alliance for Harm Minimisation & Advocacy

Ele Morrison

AIVL

Directory of Advocacy

Melanie Walker

Australian Alcohol and other Drugs Council

CEO

Webinar: Changes To The Opioid Dependence Treatment Program: Implications for Access and Transitional Arrangements

Stay up to date with our newsletter

This field is for validation purposes and should be left unchanged.